<?xml version="1.0" encoding="UTF-8"?>
<p>As the number of COVID-19 cases are rising across the world, more and more neurological manifestations involving central and peripheral nervous systems as well as skeletal muscles are coming to the surface. In one seminal work by Mao et al.
 <sup>
  <xref rid="r4" ref-type="bibr">4</xref>
 </sup>, 78 out of 214 patients studied – a whopping 36.4% – had neurological involvement. In another retrospective study from Wuhan, 6% of infected hospitalized patients developed acute cerebrovascular events following COVID-19 infection.
 <sup>
  <xref rid="r54" ref-type="bibr">54</xref>
 </sup> Outside China, a study from France by Helms et al.
 <sup>
  <xref rid="r55" ref-type="bibr">55</xref>
 </sup> found neurologic manifestations in 14% of their patients admitted to the intensive care unit (ICU), and notably in another 67% of patients once their sedation and neuromuscular blockade was withdrawn. Several other studies have shown neurologic involvement as the presenting feature of SARS-CoV-2 infection or have reported post-infectious neurologic complications.
 <sup>
  <xref rid="r3" ref-type="bibr">3</xref>,
  <xref rid="r42" ref-type="bibr">42</xref>,
  <xref rid="r56" ref-type="bibr">56</xref>–
  <xref rid="r58" ref-type="bibr">58</xref>
 </sup>
</p>
